LANIA, ANDREA GERARDO ANTONIO
 Distribuzione geografica
Continente #
EU - Europa 7.064
NA - Nord America 4.806
AS - Asia 2.224
SA - Sud America 144
AF - Africa 23
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.285
Nazione #
US - Stati Uniti d'America 4.581
GB - Regno Unito 2.762
DE - Germania 1.210
CN - Cina 1.208
IT - Italia 940
SE - Svezia 757
UA - Ucraina 308
IN - India 248
TR - Turchia 237
CA - Canada 203
KR - Corea 192
FR - Francia 184
IE - Irlanda 183
FI - Finlandia 145
EU - Europa 136
NL - Olanda 134
RU - Federazione Russa 132
HK - Hong Kong 86
CO - Colombia 80
SG - Singapore 65
BE - Belgio 62
GR - Grecia 51
VN - Vietnam 46
JP - Giappone 44
DK - Danimarca 43
ES - Italia 27
ID - Indonesia 27
BR - Brasile 26
SK - Slovacchia (Repubblica Slovacca) 21
AU - Australia 19
RO - Romania 19
AR - Argentina 17
AT - Austria 17
CL - Cile 13
MX - Messico 13
PT - Portogallo 13
TW - Taiwan 13
CH - Svizzera 11
SI - Slovenia 11
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
PL - Polonia 9
DZ - Algeria 7
IL - Israele 7
IR - Iran 7
MO - Macao, regione amministrativa speciale della Cina 7
EG - Egitto 5
NO - Norvegia 5
MA - Marocco 4
QA - Qatar 4
SA - Arabia Saudita 4
BD - Bangladesh 3
BO - Bolivia 3
GH - Ghana 3
KZ - Kazakistan 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
RS - Serbia 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
EC - Ecuador 2
IM - Isola di Man 2
LU - Lussemburgo 2
MY - Malesia 2
SC - Seychelles 2
SV - El Salvador 2
TH - Thailandia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BS - Bahamas 1
CR - Costa Rica 1
DM - Dominica 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
Totale 14.419
Città #
Southend 2.522
Chandler 669
Seattle 355
Ann Arbor 352
Houston 317
Milan 301
Beijing 294
Hanover 274
Princeton 253
Frankfurt am Main 233
Jacksonville 225
Wilmington 207
Ashburn 185
Dublin 181
Toronto 165
Dearborn 164
Redmond 145
Mountain View 125
Nanjing 120
Fairfield 113
Woodbridge 104
Serra 95
Des Moines 91
Somerville 91
Sakarya 86
Bengaluru 84
Boardman 81
Shenyang 77
Hong Kong 75
Bogotá 74
Jinan 71
Andover 68
Redwood City 58
Brussels 54
Shanghai 52
New York 48
Hangzhou 47
Grafing 39
Nanchang 38
Fuzhou 35
Helsinki 35
Athens 33
Berlin 33
Changsha 31
Kiez 30
Tianjin 30
Hebei 29
Rome 29
Eitensheim 26
Jiaxing 26
Cambridge 25
Zhengzhou 24
Bitonto 23
Auburn Hills 22
Guangzhou 22
Los Angeles 22
Bernolákovo 21
Nürnberg 21
Dong Ket 20
Hamburg 20
Phoenix 20
Ningbo 19
Seoul 18
Kunming 17
Ottawa 17
Bühl 16
Pisa 16
Taizhou 16
Chicago 15
Lanzhou 15
San Diego 15
Cinisello Balsamo 14
Mumbai 14
Haikou 13
London 13
Odernheim 13
Paris 13
Tokyo 13
Turin 13
Fremont 12
Norwalk 12
São Paulo 12
Taiyuan 12
Istanbul 10
Medford 10
Chengdu 9
Padova 9
Silver Spring 9
Taipei 9
Amsterdam 8
Falls Church 8
Naples 8
Newport 8
Pune 8
Napoli 7
Santiago 7
Sunnyvale 7
Tappahannock 7
Vienna 7
Vittuone 7
Totale 9.566
Nome #
Pseudohypoparathyroidism and GNAS epigenetic defects : clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients 481
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 384
Biallelic expression of the Gsalpha gene in human bone and adipose tissue 342
β-arrestin 2 is required for dopamine receptor type 2 inhibitory effects on AKT phosphorylation and cell proliferation in pituitary tumors 259
Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiency 220
Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein 210
Different expression of protein kinase A (PKA) regulatory subunits in normal and neoplastic thyroid tissues 209
G protein mutations in endocrine diseases 195
Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly : effects on cardiovascular risk factors 194
Efficacia e tollerabilità della radiochirurgia con tecnica gamma-knife nell’acromegalia : studio con follow-up pari a 10 anni 191
Treatment of Acromegalic Osteopathy in Real-Life Clinical Practice: The BAAC (Bone Active drugs in ACromegaly) Study 189
Analysis of genetic variants of phosphodiesterase 11A (PDE11A) in acromegalic patients 186
Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors 179
The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation 175
Effect of growth hormone deficiency and recombinant hGH (rhGH) replacement on the hypothalamic-pituitary-adrenal axis in children with idiopathic isolated GH deficiency 174
Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease 174
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas 172
Patients with macroprolactinaemia : clinical and radiological features 172
Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus : effect of glycemic control and visceral adiposity on Leydig cell function 167
La vita transnasosfronoidale nei pazienti anziani affetti da adenoma ipofisario, è veramente un intervento a bassa morbidità e mortalità 161
Is the 250 μg ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders? 157
Valutazione della funzione dell'asse ipotalamo-ipofisi-surrene in pazienti acromegalici sottoposti a trattamento chirurgico o medico con analoghi della somatostatina 156
Efficacy and tolerability of gamma knife radiosurgery in acromegaly : a 10-year follow-up study 152
GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency 148
Effect of cyclic adenosine 3',5'-monophosphate/protein kinase a pathway on markers of cell proliferation in nonfunctioning pituitary adenomas 147
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly 147
Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma 147
Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands 144
Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2 144
Effect of recombinant hGH (rhGH) replacement on gonadal function in male patients with organic adult-onset GH deficiency 144
High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells 142
Central hypothyroidism and growth hormone treatment : clinical care 141
An unusual case of recurrent autoimmune hypophysitis 141
Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors 140
Adequacy of current postglucose GH nadir limit (< 1 microg/l) to define long-lasting remission of acromegalic disease 139
Dopamine and somatostatin analogues resistance of pituitary tumors : focus on cytoskeleton involvement 138
Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients 137
The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalisation after somatostatin stimulation 136
Specific roles of Gi protein family members revealed by dissecting SST5 coupling in human pituitary cells 135
Analysis of GNAS1 and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine disorders 133
GH response to oral glucose tolerance test : a comparison between patients with acromegaly and other pituitary disorders 133
Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients 132
Trattamento chirurgico conservativo dei tumori testicolari a cellule di Leydig 130
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells 130
Growth hormone replacement therapy in growth hormone deficient children and adults : effects on hemochrome 129
The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways 129
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 129
d3-Growth hormone receptor polymorphism in acromegaly : effects on metabolic phenotype 127
Effects of chronic retinoid administration on pituitary function 126
Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation 126
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas 124
Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients 122
Protein Kinase A regulatory subunits in human adipose tissue : decreased R2B expression and activity in adipocytes from obese subjects 120
Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy 120
Expression of the antiaptotic gene seladin-1 and octreotide-induced aptosis in growth hormone-secreting and non functioning pituitary adenomas 119
Thyrotropin-secreting pituitary adenomas : outcome of pituitary surgery and irradiation 119
Gonadotropin-releasing hormone initiates multiple signaling pathways in human GH-secreting adenomas 117
Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: Relationship with cell proliferation 117
Non-functioning pituitary adenoma database : a useful resource to improve the clinical management of pituitary tumors 116
Evaluation of GH-IGF-I axis in adult patients with coeliac disease 116
Parental origin of Gsalpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors 115
Aryl hydrocarbon receptor-interacting protein and pituitary adenomas : a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident 115
Un caso di carcinoma neuroendocrino del timo determinante sindrome di Cushing da ACTH ectopico 115
Effect of 9-cis retinoic acid on dopamine D2 receptor expression in pituitary adenoma cells 114
Conservative surgical therapy for Leydig Cell Tumor 113
Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation 111
Una possibile catastrofe neurochirurgica 109
Evaluation of proopiomelanocortin mRNA in the peripheral blood from patients with Cushing's syndrome of different origin 109
null 109
Eight-year follow-up of a child with a GH/prolactin-secreting adenoma : efficacy of pegvisomant therapy 109
FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression 108
Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly 108
Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment 107
Constitutively active Gs alpha is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas 106
Evaluation of the Components of the Insulin-like Growth Factors System in GH-deficient Adults: Effects of Twelve-month rhGH Treatment 105
Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia 105
Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac) 105
Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acromegaly 105
Genetic abnormalities of somatostatin receptors in pituitary tumors 104
Preliminary data on biochemical remission of acromegaly after somatostatin analogs withdrawal 104
Double pituitary and conserved function in an adult patient with neurofibromatosis type 1 102
Cytoskeleton protein Filamin A is required for efficient Somatostatin receptor type 2 internalization and recycling through Rab5 and Rab4 sorting endosomes in tumor somatotroph cells 102
Diagnostic features and outcome of surgical therapy of acromegalic patients : experience of the last three decades 99
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 99
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients : a multicenter study 98
Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib 97
Central hypothyroidism 95
Un caso di macroadenoma misto PRL/TSH secernente : diagnosi e terapia 93
Activating mutations of the Gsα gene are associated with low levels of Gsα protein in growth hormone-secreting tumors 92
Expression of protein kinase A regulatory subunits in benign and malignant human thyroid tissues : a systematic review 92
Remissione della malattia acromegalica dopo sospensione del trattamento con analoghi della somatostatina 91
Modulation of cyclin D1 expression in human tumoral parathyroid cells : effects of growth factors and calcium sensing receptor activation 91
Hormonal signaling and pituitary adenomas 89
The trans-sphenoidal resection of pituitary adenomas in elderly patients and surgical risk 88
Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs 88
Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression 85
cAMP pathway and pituitary tumorigenesis 84
Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations 83
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 82
A potential catastrophic trap : an unusually presenting sellar lesion 81
Totale 13.790
Categoria #
all - tutte 33.948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.948


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019376 0 0 0 0 0 0 0 0 0 0 169 207
2019/20202.044 239 54 121 209 133 181 318 169 243 214 89 74
2020/20211.888 62 116 184 36 137 121 139 148 275 170 394 106
2021/20221.656 112 39 153 102 148 96 149 91 217 137 87 325
2022/20232.308 241 244 188 236 225 379 92 199 222 58 131 93
2023/20241.164 71 94 69 95 417 55 95 101 26 105 36 0
Totale 15.200